No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Proactive News Headlines Including Piedmont Lithium, Tempus Resources, Creso Pharma Ltd and Southern Gold
BRIEF-Creso Pharma Ltd Provides Mernova Update
Creso Pharma Ltd (COPHF) Stock Declines -22.22% This Week; Should You Buy?
